<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 30 May 2021 07:33:30 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>创新药、疫苗、CDMO，本周三大医药新势力IPO，谁更强势？</title><link>https://mp.weixin.qq.com/s/VdGzI1QUkpPSUy1i5Pci-g</link><description></description><content:encoded><![CDATA[创新药、疫苗、CDMO，本周三大医药新势力IPO，谁更强势？]]></content:encoded><pubDate>Sat, 29 May 2021 21:44:30 +0800</pubDate></item><item><title>【药咖君】 1 类抗菌药「康泰唑胺片」即将获批！利格列汀片已有3家过评，石药、齐鲁…</title><link>https://mp.weixin.qq.com/s/kDoJ7_DcHGjm1aOaNCPQpg</link><description></description><content:encoded><![CDATA[【药咖君】 1 类抗菌药「康泰唑胺片」即将获批！利格列汀片已有3家过评，石药、齐鲁…]]></content:encoded><pubDate>Sat, 29 May 2021 21:44:30 +0800</pubDate></item><item><title>独家专访！全面落实MAH制度后，药企发展4点关键</title><link>https://mp.weixin.qq.com/s/Ns5qoMjqnm5lp0P5fFNgbw</link><description></description><content:encoded><![CDATA[独家专访！全面落实MAH制度后，药企发展4点关键]]></content:encoded><pubDate>Fri, 28 May 2021 18:04:22 +0800</pubDate></item><item><title>演讲嘉宾公布！第六届中国医药研发·创新峰会（PDI）邀您共赴行业盛会</title><link>https://mp.weixin.qq.com/s/DFGHkd7gG0-8SVi65JjMFQ</link><description></description><content:encoded><![CDATA[演讲嘉宾公布！第六届中国医药研发·创新峰会（PDI）邀您共赴行业盛会]]></content:encoded><pubDate>Fri, 28 May 2021 18:04:22 +0800</pubDate></item><item><title>CAR-T疗法靶点多元化！传奇生物西达基奥仑赛获FDA优先审评，复星凯特、药明巨诺...</title><link>https://mp.weixin.qq.com/s/wfKjA_2bx7yHVDcDdWgidQ</link><description></description><content:encoded><![CDATA[CAR-T疗法靶点多元化！传奇生物西达基奥仑赛获FDA优先审评，复星凯特、药明巨诺...]]></content:encoded><pubDate>Fri, 28 May 2021 17:50:28 +0800</pubDate></item><item><title>奇怪？1季度基金大量减持医药股，却为何这4家企业例外</title><link>https://mp.weixin.qq.com/s/Na-0nOuOd6ACHZesVU_MAQ</link><description></description><content:encoded><![CDATA[奇怪？1季度基金大量减持医药股，却为何这4家企业例外]]></content:encoded><pubDate>Fri, 28 May 2021 17:50:28 +0800</pubDate></item><item><title>双抗大战将至！谁在“死亡之组”？百济、信达、康方谁将是全球第五款？安进走“弯路”后将如何破局？</title><link>https://mp.weixin.qq.com/s/ulEKc9kHYLbOBB-baaIBTQ</link><description></description><content:encoded><![CDATA[双抗大战将至！谁在“死亡之组”？百济、信达、康方谁将是全球第五款？安进走“弯路”后将如何破局？]]></content:encoded><pubDate>Fri, 28 May 2021 17:50:28 +0800</pubDate></item><item><title>肺癌靶向药物的“速度与激情”</title><link>https://mp.weixin.qq.com/s/zARVS_fTYSSzRvIQsXQMag</link><description></description><content:encoded><![CDATA[肺癌靶向药物的“速度与激情”]]></content:encoded><pubDate>Fri, 28 May 2021 17:50:28 +0800</pubDate></item><item><title>最新！基药扩容，新增270个品种？哪些品种将优先入围集采？</title><link>https://mp.weixin.qq.com/s/FH9CylrkoQsPEx4hR6E9Yw</link><description></description><content:encoded><![CDATA[最新！基药扩容，新增270个品种？哪些品种将优先入围集采？]]></content:encoded><pubDate>Thu, 27 May 2021 17:59:54 +0800</pubDate></item><item><title>2021医药人薅羊毛实录！不说了，看完直接安排！</title><link>https://mp.weixin.qq.com/s/R92rQ0mQBSXPe5TbDrH_7Q</link><description></description><content:encoded><![CDATA[2021医药人薅羊毛实录！不说了，看完直接安排！]]></content:encoded><pubDate>Thu, 27 May 2021 17:59:54 +0800</pubDate></item><item><title>这些品种，一致性评价最热门（附名单）</title><link>https://mp.weixin.qq.com/s/-sms8cfIDwphXbV6CCHyIA</link><description></description><content:encoded><![CDATA[这些品种，一致性评价最热门（附名单）]]></content:encoded><pubDate>Thu, 27 May 2021 17:59:54 +0800</pubDate></item><item><title>幼儿好发“手足口病”，最怕老师通知集体放假一周，如何预防？</title><link>https://mp.weixin.qq.com/s/o_-BUmZ6oJpQlSzPmEPqAg</link><description></description><content:encoded><![CDATA[幼儿好发“手足口病”，最怕老师通知集体放假一周，如何预防？]]></content:encoded><pubDate>Thu, 27 May 2021 17:59:54 +0800</pubDate></item><item><title>一致性评价Top10品种分析：过评339个，齐鲁一骑红尘，石药、科伦紧跟</title><link>https://mp.weixin.qq.com/s/NelbtjSnPvMvo9NKNTJQMw</link><description></description><content:encoded><![CDATA[一致性评价Top10品种分析：过评339个，齐鲁一骑红尘，石药、科伦紧跟]]></content:encoded><pubDate>Wed, 26 May 2021 17:53:50 +0800</pubDate></item><item><title>8.65亿元年薪！力压“老牌”强生、礼来、默沙东等MNC，谁才是2020最“壕”药企CEO？</title><link>https://mp.weixin.qq.com/s/XLwI4YnJUe2fh5SxfgMr5Q</link><description></description><content:encoded><![CDATA[8.65亿元年薪！力压“老牌”强生、礼来、默沙东等MNC，谁才是2020最“壕”药企CEO？]]></content:encoded><pubDate>Wed, 26 May 2021 17:53:50 +0800</pubDate></item><item><title>分析报告：数字化转型浪潮下，药企重塑核心竞争力</title><link>https://mp.weixin.qq.com/s/C0Xoul5Zbi5v2w7NrW2VAQ</link><description></description><content:encoded><![CDATA[分析报告：数字化转型浪潮下，药企重塑核心竞争力]]></content:encoded><pubDate>Wed, 26 May 2021 17:53:50 +0800</pubDate></item><item><title>国内超10家企业扎根一次性内窥镜领域，是否能加速国产替代，与国外巨头并肩？</title><link>https://mp.weixin.qq.com/s/M0eid6-PCVZSxOCYXmo7ZA</link><description></description><content:encoded><![CDATA[国内超10家企业扎根一次性内窥镜领域，是否能加速国产替代，与国外巨头并肩？]]></content:encoded><pubDate>Wed, 26 May 2021 17:53:50 +0800</pubDate></item><item><title>200亿市场“危机四伏”！生长激素能否真的被纳入集采？</title><link>https://mp.weixin.qq.com/s/ilHEfVhPiqKl19G_EYFUcQ</link><description></description><content:encoded><![CDATA[200亿市场“危机四伏”！生长激素能否真的被纳入集采？]]></content:encoded><pubDate>Tue, 25 May 2021 17:57:35 +0800</pubDate></item><item><title>国产创新集体出海，多项重磅研究临床数据公布！恒瑞、豪森…</title><link>https://mp.weixin.qq.com/s/EbNUA1qpVSQqZBHQB6r3rg</link><description></description><content:encoded><![CDATA[国产创新集体出海，多项重磅研究临床数据公布！恒瑞、豪森…]]></content:encoded><pubDate>Tue, 25 May 2021 17:57:35 +0800</pubDate></item><item><title>NEJM重磅：阿司匹林40年难题迎来答案，更推荐低剂量用于心血管疾病</title><link>https://mp.weixin.qq.com/s/M9RxtEbx8yrwTdlBrajyjA</link><description></description><content:encoded><![CDATA[NEJM重磅：阿司匹林40年难题迎来答案，更推荐低剂量用于心血管疾病]]></content:encoded><pubDate>Tue, 25 May 2021 17:57:35 +0800</pubDate></item><item><title>多家药企卷入行贿案，被曝光！</title><link>https://mp.weixin.qq.com/s/dgk9zOLqGE1GJFB9hKFMyw</link><description></description><content:encoded><![CDATA[多家药企卷入行贿案，被曝光！]]></content:encoded><pubDate>Tue, 25 May 2021 17:57:35 +0800</pubDate></item></channel></rss>